Shikiar Asset Management Inc Avenue Therapeutics, Inc. Transaction History

Shikiar Asset Management Inc

  • $343 Million
  • Q1 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023
BUY
$0.91 - $1.29 $22,750 - $32,250
25,000 New
25,000 $29,000

About AVENUE THERAPEUTICS, INC.

ATXI Quotes by TradingView
  • Ticker ATXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,127,720
  • Market Cap $14.1M
  • Description
  • Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...
More about ATXI
Track This Portfolio

Track Shikiar Asset Management Inc Portfolio

Follow Shikiar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email